DeZwarteRidder 5 augustus 2020 14:06 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 Company press releasesDisplaying 21 - 40 of 110 resultsReleased Company Title Industry Topic01 Jul 201907:17 CEST ESPERITE ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE. Biotechnology Alliances and agreements30 Jun 201921:01 CEST ESPERITE ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business. Biotechnology New28 Jun 201923:51 CEST ESPERITE Esperite N.V.: Update to the market on the publication of the Annual Report 2018 Biotechnology New25 Jun 201922:59 CEST ESPERITE ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM Biotechnology Other subject14 Jun 201908:54 CEST ESPERITE ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes Biotechnology Other subject13 Jun 201907:17 CEST ESPERITE ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM Biotechnology Other subject04 Jun 201910:18 CEST ESPERITE Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution. Biotechnology Other subject29 May 201908:26 CEST ESPERITE ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale Biotechnology Other subject19 May 201922:54 CEST ESPERITE ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019) Biotechnology Other subject13 May 201907:17 CEST ESPERITE Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration. Biotechnology Other subject01 May 201916:58 CEST ESPERITE Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018 Biotechnology Other subject05 Apr 201907:17 CEST ESPERITE ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund Biotechnology Other subject27 Feb 201907:17 CET ESPERITE Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia. Biotechnology Other subject26 Feb 201907:17 CET ESPERITE ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund Biotechnology Other subject22 Feb 201907:17 CET ESPERITE ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS. Biotechnology Other subject10 Jan 201907:17 CET ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today Biotechnology Other subject30 Nov 201807:17 CET ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today Biotechnology Other subject29 Nov 201807:17 CET ESPERITE Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates. Biotechnology Other subject27 Nov 201818:26 CET ESPERITE ESPERITE N.V. convenes Annual General Meeting of Shareholders Biotechnology Other subject23 Nov 201823:35 CET ESPERITE ESPERITE (ESP): financial results for 2017 are published. Biotechnology Other subject Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 5 augustus 2020 14:07 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 Met nepnieuws bedoel ik nieuws wat bedoelt is om de aandeelhouders te misleiden. Aanbevelingen 1 ” Quote Reageren Niet oké
DeZwarteRidder 5 augustus 2020 14:09 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 Company press releasesDisplaying 41 - 60 of 110 resultsReleased Company Title Industry Topic19 Nov 201815:35 CET ESPERITE ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018 Biotechnology Other subject09 Nov 201807:17 CET ESPERITE ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018 Biotechnology Other subject07 Nov 201807:17 CET ESPERITE Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada. Biotechnology Other subject06 Nov 201808:56 CET ESPERITE Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia. Biotechnology Other subject15 Oct 201807:17 CEST ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today Biotechnology Other subject03 Oct 201818:18 CEST ESPERITE Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled Biotechnology Other subject13 Sep 201807:17 CEST ESPERITE ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA. Biotechnology Other subject31 Aug 201807:17 CEST ESPERITE Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017. Biotechnology Other subject29 Aug 201807:17 CEST ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today Biotechnology Other subject15 Aug 201807:17 CEST ESPERITE Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017. Biotechnology Other subject18 Jul 201808:26 CEST ESPERITE Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017 Biotechnology Other subject02 Jul 201807:17 CEST ESPERITE ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI). Biotechnology Other subject28 Jun 201807:17 CEST ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investment today Biotechnology Other subject19 Jun 201807:17 CEST ESPERITE Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies Biotechnology Other subject18 Jun 201822:24 CEST ESPERITE ESPERITE (ESP) further delays publication of Annual Report 2017. Biotechnology Other subject12 Jun 201807:17 CEST ESPERITE European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding Biotechnology Other subject06 Jun 201808:26 CEST ESPERITE ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES. Biotechnology Other subject05 Jun 201807:17 CEST ESPERITE ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018 Biotechnology Other subject17 May 201814:33 CEST ESPERITE Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease. Biotechnology Other subject17 May 201807:17 CEST ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today Biotechnology Other subject Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 5 augustus 2020 14:10 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 Company press releasesDisplaying 61 - 80 of 110 resultsReleased Company Title Industry Topic16 May 201809:31 CEST ESPERITE ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION Biotechnology Other subject03 May 201811:36 CEST ESPERITE Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke Biotechnology Other subject30 Apr 201812:55 CEST ESPERITE ESPERITE NV (ESP) delays publication of Annual Report 2017 Biotechnology Other subject11 Apr 201807:17 CEST ESPERITE ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018. Biotechnology Other subject29 Mar 201809:15 CEST ESPERITE Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases Biotechnology Other subject02 Mar 201807:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today Biotechnology Other subject16 Feb 201807:17 CET ESPERITE ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018. Biotechnology Other subject31 Jan 201813:26 CET ESPERITE ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale. Biotechnology Other subject31 Jan 201807:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today Biotechnology Other subject16 Jan 201807:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today Biotechnology Other subject10 Jan 201815:07 CET ESPERITE ESPERITE (ESP) : transfers its laboratory activity to Geneva and consequently sells its Belgium loss making subsidiary and avoids EUR 4 millions of future cash out for charges and financial costs Biotechnology Other subject10 Jan 201807:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 12th tranche of investment today Biotechnology Other subject08 Jan 201812:59 CET ESPERITE ESPERITE (ESP): CEO Frederic Amar converts a portion of his Loan Note into 1.5 million shares. Biotechnology Other subject05 Jan 201810:56 CET ESPERITE ESPERITE (ESP): issues EUR 400'000 convertible note for additional financing provided by CEO Frederic Amar Biotechnology Other subject22 Dec 201707:17 CET ESPERITE ESPERITE (ESP): EUR 1 million of new funding provided by European Select Growth Opportunities Fund until February 23, 2018 Biotechnology Other subject17 Nov 201708:19 CET ESPERITE ESPERITE N.V. (ESP) , Stabilisation before growth. Biotechnology Other subject09 Nov 201708:54 CET ESPERITE ESPERITE (ESP) : L1 Capital invests for total EUR 500K today by subscribing to the Tenth tranche (EUR 250K) and shows confidence by investing additionally EUR 250K under the same conditions. Biotechnology Other subject09 Nov 201707:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions. Biotechnology Other subject30 Oct 201707:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the Ninth tranche of investment today Biotechnology Other subject10 Oct 201708:52 CEST ESPERITE ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies Biotechnology Other subject Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 5 augustus 2020 14:11 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 Company press releasesDisplaying 81 - 100 of 110 resultsReleased Company Title Industry Topic10 Oct 201707:17 CEST ESPERITE ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies Biotechnology Other subject02 Oct 201707:17 CEST ESPERITE ESPERITE N.V. (ESP) publishes its half-year report. Revenues and results were unexpectedly impacted by pending legal actions. Biotechnology Other subject29 Sep 201721:16 CEST ESPERITE ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting Biotechnology Other subject31 Aug 201707:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today Biotechnology Other subject11 Aug 201707:17 CEST ESPERITE ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017 Biotechnology Other subject05 Jul 201707:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today Biotechnology Other subject15 Jun 201707:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today Biotechnology Other subject01 Jun 201707:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the second packed tranche today, ahead of schedule Biotechnology Other subject31 May 201708:52 CEST ESPERITE ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017 Biotechnology Other subject31 May 201708:26 CEST ESPERITE ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017 Biotechnology Other subject31 May 201707:57 CEST ESPERITE ESPERITE (ESP) Q1 consolidated revenue higher compared to budget Biotechnology Other subject31 May 201707:17 CEST ESPERITE ESPERITE (ESP) has concluded new agreements with its note holders Biotechnology Other subject23 May 201715:44 CEST ESPERITE ESPERITE N.V. convenes Annual General Meeting of Shareholders Biotechnology Other subject23 May 201707:17 CEST ESPERITE ESPERITE (ESP) financial results for 2016 published Biotechnology Other subject20 May 201718:28 CEST ESPERITE Esperite further delays publication of 2016 Annual Report Biotechnology Other subject19 May 201713:20 CEST ESPERITE Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court Biotechnology Other subject15 May 201710:17 CEST ESPERITE Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT) Biotechnology Other subject15 May 201710:17 CEST ESPERITE Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT) Biotechnology Other subject15 May 201707:17 CEST ESPERITE Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT) Biotechnology Other subject15 May 201707:17 CEST ESPERITE Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT) Biotechnology Other subject Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 5 augustus 2020 14:11 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 Company press releasesDisplaying 101 - 110 of 110 resultsReleased Company Title Industry Topic11 May 201709:27 CEST ESPERITE Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology Biotechnology Other subject05 May 201709:08 CEST ESPERITE Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy Biotechnology Other subject26 Apr 201707:17 CEST ESPERITE ESPERITE delays publication of 2016 Annual Report Biotechnology Other subject25 Apr 201707:17 CEST ESPERITE ESPERITE N.V. (ESP) WITH CRYOSAVE CONTRIBUTES TO TREATING A 9 YEAR OLD CHILD WITH THALASSEMIA MAJOR IN SWITZERLAND Biotechnology Other subject24 Apr 201707:17 CEST ESPERITE ESPERITE's shareholders approved the external financing of up to EUR 13 million Biotechnology Other subject31 Mar 201722:06 CEST ESPERITE CryoSave e Crioestaminal chegaram a um acordo para a armazenagem das células estaminais da Bioteca Biotechnology Other subject10 Mar 201714:29 CET ESPERITE Esperite N.V. convenes Extraordinary General Meeting of Shareholders regarding external financing of up to EUR 13 million Biotechnology Other subject08 Mar 201708:26 CET ESPERITE Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies Biotechnology Other subject08 Mar 201707:17 CET ESPERITE Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies Biotechnology Other subject28 Feb 201708:55 CET ESPERITE Esperite N.V.: Update on Financing Biotechnology Other subject Aanbevelingen 0 ” Quote Reageren Niet oké
Amarillo 5 augustus 2020 15:13 auteur info Amarillo Lid sinds: 22 jun 2020 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 138 Gegeven: 27 Aantal posts: 1.486 Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 5 augustus 2020 15:32 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 quote:Amarillo schreef op 5 augustus 2020 15:13:Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggennSlimme mensen leren van het verleden.Iemand die deze berichten goed leest begrijpt dat hij wordt opgelicht.Ik wil newbies een eerlijke kans geven om hun geld al dan niet weg te gooien. Aanbevelingen 1 ” Quote Reageren Niet oké
Amarillo 6 augustus 2020 07:34 auteur info Amarillo Lid sinds: 22 jun 2020 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 138 Gegeven: 27 Aantal posts: 1.486 Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 6 augustus 2020 07:42 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 quote:Amarillo schreef op 6 augustus 2020 07:34:Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst Dat geldt natuurlijk ook voor jou met je opschepperij. Aanbevelingen 0 ” Quote Reageren Niet oké
Amarillo 6 augustus 2020 08:45 auteur info Amarillo Lid sinds: 22 jun 2020 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 138 Gegeven: 27 Aantal posts: 1.486 We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker?? Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 6 augustus 2020 08:59 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 quote:Amarillo schreef op 6 augustus 2020 08:45:We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker?? Het is opvallend maar niet verbazingwekkend dat jij nooit ingaat op inhoudelijke zaken m.b.t. Esperite.Gelukkig kun je nog terecht in Benidorm, want daar kunnen ze altijd proppers gebruiken. Aanbevelingen 1 ” Quote Reageren Niet oké
Amarillo 10 augustus 2020 16:47 auteur info Amarillo Lid sinds: 22 jun 2020 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 138 Gegeven: 27 Aantal posts: 1.486 Gelukkig vetrouwd ridder blind op dubieuze geert.. Aanbevelingen 0 ” Quote Reageren Niet oké
DeZwarteRidder 10 augustus 2020 16:52 auteur info DeZwarteRidder Lid sinds: 29 jun 2012 Laatste bezoek: 19 apr 2024 Aanbevelingen Ontvangen: 20754 Gegeven: 9428 Aantal posts: 96.617 quote:Amarillo schreef op 10 augustus 2020 16:47:Gelukkig vetrouwd ridder blind op dubieuze geert..Ik heb helemaal niks met Geert, zelfs geen abonnement. Aanbevelingen 0 ” Quote Reageren Niet oké
Beurscodes, betekenis en hulp bij zoeken Europa AEX Euronext Amsterdam BRU Euronext Brussels PSE Euronext Paris LIS Euronext Lissabon CHX CBOE Europe, grote(re) EU aandelen NAV Investment Funds (NAV) Noord-Amerika NYS New York Stock Exchange OTC CBOE BZX Exchange (US) TSE Toronto Stock Exchange Kunt u een instrument niet vinden? Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code. Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze. Waar vind ik die ISIN code? Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'. Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.